POLICY DIRECTIONS INC. for CELLERANT THERAPEUTICS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 16, 2012 | — | Replaced |
| 1st Quarter - Amendment (No Activity) | Apr 16, 2012 | — | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Increased funding for Biodefense advanced research development through BARDA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN MICHAEL | — |
| FRANKIE L TRULL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.